Sinecod (citrate butamirate) drops oral for children 5 mg/ml. 20 ml. vial

$16.00

Manufacturer: Italy

Purpose: Suppress cough by targeting respiratory centers in the brainstem.

SKU: MED61287 Categories: , ,

Description

Sinecod (Citrate Butamirate) Drops Oral for Children 5 mg/ml. 20 ml Vial

Ingredients

Active ingredient: Citrate Butamirate. Other ingredients may include glycerol, propylene glycol, sodium saccharin, and purified water.

Dosage

Children 2-6 years: 5-10 drops 3 times a day. Children 6-12 years: 10-20 drops 3 times a day. The drops can be diluted in water or juice.

Indications

Sinecod drops are indicated for the relief of cough in children due to various respiratory conditions such as bronchitis, tracheitis, and bronchiolitis.

Contraindications

Do not use Sinecod drops in children:
– With hypersensitivity to the active substance or any of the excipients.
– With a history of allergic reactions to similar medications.

Directions

Shake well before use. Use the provided dropper to measure the correct dose. Administer orally according to the prescribed dosage for the child’s age group.

Scientific Evidence

Studies have shown that citrate butamirate, the active ingredient in Sinecod drops, has antitussive (cough-suppressant) properties by acting on the cough center in the brainstem. Research published in the Journal of Pediatrics and Child Health demonstrated the efficacy of citrate butamirate in reducing cough frequency and intensity in children with acute respiratory infections.

Additional Information

It is important to follow the recommended dosage and not exceed the prescribed frequency of administration. If the child’s condition worsens or does not improve after a few days of treatment, consult a healthcare professional. Store the drops in a cool, dry place away from direct sunlight.

Pharmacological Effects: Citrate butamirate acts centrally on the cough center in the medulla oblongata, reducing the sensitivity of the cough reflex and decreasing the frequency and intensity of coughing.

Comparative Effectiveness: In comparative studies against other antitussive agents, citrate butamirate has shown similar efficacy in managing cough symptoms in children with respiratory conditions, with a favorable safety profile.